Home > > > > > Report Detail

Investigation Report on China Telmisartan Market, 2010-2019

Publisher Name :
Date: 18-Jun-2015
No. of pages: 30

The number of hypertension patients in China is estimated to surpass 300 million with one in three adults suffering from it.

Out of all the dyazides, angiotension receptor blocker (ARB) is among a new generation which grows fast. Ever since the appearance of losartan which has been first applied in the clinic, 8 kinds of similar drugs have come out for sale and there are also 5 kinds of generic drugs in China. In recent years, telmisartan could be said as the fastest-growing kind of dyazide.

First developed by Boehringer-Ingelheim (Germany) and first marketed in the US in 1999 under the trade name of Micardis, telmisartan is an oral drug for the treatment of essential hypertension which should be taken once a day. It was marketed by Boehringer-Ingelheim under the trade name of Micardis and by Glaxo Wellcome plc under the trade name of Pritor in Germany in the same year. Telmisartan entered the Philippines in Dec. 1999 and Australia, Belgium, Britain in 2000. In 2013, its sales value surpassed USD 3 billion in the world. The patent of telmisartan expired in 2014.

The active pharmaceutical ingredients (APIs) and preparations of telmisartan were introduced by Boehringer-Ingelheim into China for sales at the end of 2000. After entering China, telmisartan grows fast with annual sales value rising from less than CNY 13 million in 2005 to CNY 200 million in 2014 and CAGR during this period reaching up to 35.8% despite a slight fall in 2014. Currently, telmisartan in the Chinese market mainly come from the following companies: Boehringer-Ingelheim (Germany), China Resources Double Crane Pharmaceutical Co., Ltd, Yichang Changjiang Pharmaceutical Co., Ltd, Wanbang Biopharmaceuticals and Hainan Selection Pharmaceutical Co., Ltd, among which Boehringer-Ingelheim (Germany) has the largest market share of over 80%, sales value in 2014 reaching up to CNY 167 million.

The market size of telmisartan in China is estimated to keep growing in the next few years.

Readers can get at least the following information from this report:


  • market size of telmisartan in China

  • competitive landscape of telmisartan in Chinese market

  • price of telmisartan made by different manufactures in China

  • market outlook of telmisartan in China


The author suggests the following groups of people purchase this report:


  • manufacturers of dyazide

  • investors/ research institutions interested in Chinese medicine market

  • any interest in the Chinese medicine market, please contact CRI for customized survey service


Companies Mentioned

BoehringerIngelheim; China Resources Double Crane Pharmaceutical Co., Ltd; Yichang Changjiang Pharmaceutical Co., Ltd; Wanbang Biopharmaceuticals; Hainan Selection Pharmaceutical Co., Ltd

Investigation Report on China Telmisartan Market, 2010-2019

Table of Contents

1 Related Concepts of Telmisartan
1.1 Indication
1.2 Sales Status in Global Market

2 Market Profile of Telmisartan in China
2.1 Patent and Approval Status of Telmisartan in China
2.2 Major Manufacturers
2.3 Market Size

3 Survey on Sales Status of Telmisartan in China, 2010-2014
3.1 Sales Value
3.1.1 Overall Sales Value
3.1.2 Sales Value by Regions
3.2 Sales Volume
3.2.1 Overall Sales Volume
3.2.2 Sales Volume by Regions

4 Survey on Market Share of Major Manufacturers of Telmisartan in China, 2010-2014
4.1 Market Share by Sales Value
4.2 Market Share by Sales Volume

5 Survey on Dosage Forms of Telmisartan in China, 2010-2014
5.1 Share of Different Dosage Forms by Sales Value
5.2 Share of Different Dosage Forms by Sales Volume

6 Reference Price of Telmisartan in Chinese Hospitals in 2014
6.1 Boehringer-Ingelheim (Germany) (Trade Name: Micardis)
6.2 Beijing Wansheng Pharmaceutical Co., Ltd (Trade Name: Shu Ni Ya)
6.3 China Resources Double Crane Pharmaceutical Co., Ltd (Trade Name: Su He)
6.4 Yichang Changjiang Pharmaceutical Co., Ltd (Trade Name: Ou Mei Ning)
6.5 Wanbang Biopharmaceuticals (Trade Name: Bang Tan)
6.6 Hainan Selection Pharmaceutical Co., Ltd (Trade Name: Li Wen)
6.7 Dawnrays Pharmaceutical Limited (Trade Name: An Nei Qiang)

7 Major Manufacturers of Telmisartan in Chinese Market, 2010-2014
7.1 Boehringer-Ingelheim
7.2 China Resources Double Crane Pharmaceutical Co., Ltd
7.3 Yichang Changjiang Pharmaceutical Co., Ltd
7.4 Wanbang Biopharmaceuticals
7.5 Hainan Selection Pharmaceutical Co., Ltd

8 Market Outlook of Telmisartan in China, 2015-2019
8.1 Forecast of Market Size
8.2 Forecast of Competitive Landscape

List of Charts

Chart Patent Status of Telmisartan in China
Chart Approval Information of Telmisartan in China
Chart Sales Status of Telmisartan in China
Chart Sales Value of Telmisartan in China, 2010-2014
Chart Sales Value of Telmisartan in Some Regions in China, 2010-2014
Chart Sales Volume of Telmisartan in China, 2010-2014
Chart Sales Volume of Telmisartan in Some Regions in China, 2010-2014
Chart Market Share of TOP4 Manufacturers of Telmisartan for Sales Value in China, 2010-2014
Chart Sales Value and Market Share of Telmisartan Made by Boehringer-Ingelheim (Germany) in China, 2010-2014
Chart Sales Value and Market Share of Telmisartan Made by Yichang Changjiang in China, 2010-2014
Chart Sales Value and Market Share of Telmisartan Made by China Resources Double Crane in China, 2010-2014
Chart Sales Value and Market Share of Telmisartan Made by Hainan Selection in China, 2010-2014
Chart Sales Value and Market Share of Telmisartan Tablets in China, 2010-2014
Chart Sales Value and Market Share of Telmisartan Capsules in China, 2010-2014
Chart Price of Telmisartan Made by Boehringer-Ingelheim (Germany) in Some Chinese Cities in 2014
Chart Price of Telmisartan Made by Beijing Wansheng Pharmaceutical Co., Ltd in Some Chinese Cities in 2014
Chart Price of Telmisartan Made by China Resources Double Crane Pharmaceutical Co., Ltd in Some Chinese Cities in 2014
Chart Price of Telmisartan Made by Yichang Changjiang Pharmaceutical Co., Ltd in Some Chinese Cities in 2014
Chart Price of Telmisartan Made by Wanbang Biopharmaceuticals in Some Chinese Cities in 2014
Chart Price of Telmisartan Made by Hainan Selection Pharmaceutical Co., Ltd in Some Chinese Cities in 2014
Chart Price of Telmisartan Made by Dawnrays Pharmaceutical Limited in Some Chinese Cities in 2014

  • Global Pulmonary Arterial Hypertension (Pah) Medicine Industry Research Report, In-depth Analysis of Current Status and Outlook of Key Countries 2023-2028
    Published: 04-Jan-2024        Price: US 3380 Onwards        Pages: 103
    Market Overview of Global Pulmonary Arterial Hypertension (Pah) Medicine market: According to our latest research, the global Pulmonary Arterial Hypertension (Pah) Medicine market looks promising in the next 5 years. As of 2022, the global Pulmonary Arterial Hypertension (Pah) Medicine market was estimated at USD XX million, and it's anticipated to reach USD XX million in 2028, with a CAGR of XX% during the forecast years. This report covers a research time span from 2018 to ......
  • Global Nifedipine Industry Research Report, In-depth Analysis of Current Status and Outlook of Key Countries 2023-2028
    Published: 04-Jan-2024        Price: US 3380 Onwards        Pages: 102
    Market Overview of Global Nifedipine market: According to our latest research, the global Nifedipine market looks promising in the next 5 years. As of 2022, the global Nifedipine market was estimated at USD XX million, and it's anticipated to reach USD XX million in 2028, with a CAGR of XX% during the forecast years. This report covers a research time span from 2018 to 2028, and presents a deep and comprehensive analysis of the global Nifedipine market, with a systematical de......
  • Global Amlodipine Besylate Market Research Report 2024
    Published: 04-Jan-2024        Price: US 2900 Onwards        Pages: 115
    The Amlodipine Besylate market size, estimations, and forecasts are provided in terms of sales volume (K Units) and revenue ($ millions), considering 2023 as the base year, with history and forecast data for the period from 2019 to 2030. This report segments the global Amlodipine Besylate market comprehensively. Regional market sizes, concerning products by Type, by Application, and by players, are also provided. For a more in-depth understanding of the market, the report provides profil......
  • Pulmonary Arterial Hypertension (PAH) Drugs - Global Market Insights and Sales Trends 2024
    Published: 25-Dec-2023        Price: US 3350 Onwards        Pages: 112
    The global Pulmonary Arterial Hypertension (PAH) Drugs market size is expected to reach US$ million by 2029, growing at a CAGR of % from 2023 to 2029. The market is mainly driven by the significant applications of Pulmonary Arterial Hypertension (PAH) Drugs in various end use industries. The expanding demands from the Hospitals, Clinics and Other,, are propelling Pulmonary Arterial Hypertension (PAH) Drugs market. Inhalation, one of the segments analysed in this report, is projected to record % ......
  • Captopril API - Global Market Insights and Sales Trends 2024
    Published: 25-Dec-2023        Price: US 3350 Onwards        Pages: 100
    The global Captopril API market size is expected to reach US$ million by 2029, growing at a CAGR of % from 2023 to 2029. The market is mainly driven by the significant applications of Captopril API in various end use industries. The expanding demands from the Captopril Tablet, Compound Captopril Tablet and Captopril Injection,, are propelling Captopril API market. 98% Captopril API, one of the segments analysed in this report, is projected to record % CAGR and reach US$ million by the end of the......
  • Telmisartan - Global Market Insights and Sales Trends 2024
    Published: 21-Dec-2023        Price: US 3350 Onwards        Pages: 107
    The global Telmisartan market size is expected to reach US$ 3631.3 million by 2029, growing at a CAGR of 3.4% from 2023 to 2029. The market is mainly driven by the significant applications of Telmisartan in various end use industries. The expanding demands from the Hospital, Clinic and Others,, are propelling Telmisartan market. Injection, one of the segments analysed in this report, is projected to record % CAGR and reach US$ million by the end of the analysis period. Growth in the Freeze-Dried......
  • Global Ambrisentan Professional Survey Report 2023, Forecast to 2028
    Published: 20-Dec-2023        Price: US 3280 Onwards        Pages: 106
    Ambrisentan is a drug indicated for use in the treatment of pulmonary hypertension. The peptide endothelin constricts muscles in blood vessels, increasing blood pressure. Ambrisentan, which relaxes those muscles, is an endothelin receptor antagonist, and is selective for the type A endothelin receptor. Our market research experts provide qualitative and quantitative analysis of the market based on involving economic and non-economic factors in the same report with market value (million US......
  • Global Ambrisentan Market Research Report 2023, Forecast to 2028
    Published: 20-Dec-2023        Price: US 2680 Onwards        Pages: 132
    Ambrisentan is a drug indicated for use in the treatment of pulmonary hypertension. The peptide endothelin constricts muscles in blood vessels, increasing blood pressure. Ambrisentan, which relaxes those muscles, is an endothelin receptor antagonist, and is selective for the type A endothelin receptor. Our market research experts provide qualitative and quantitative analysis of the market based on involving economic and non-economic factors in the same report with market value (million US......
  • Global Amlodipine Besylate Professional Survey Report 2023, Forecast to 2028
    Published: 20-Dec-2023        Price: US 3280 Onwards        Pages: 133
    Our market research experts provide qualitative and quantitative analysis of the market based on involving economic and non-economic factors in the same report with market value (million USD) data for each segment and sub-segment. This way, clients can achieve all their goals while taking advantage of emerging opportunities. Technological advancements, new product launches, and market capital flows are compared across scenarios to demonstrate their impact over the forecast period. D......
    • SERVICES
    Value for Money
    We believe in "optimum utilization of available budget and resources". While servicing our clients' (your) market research requirements, we keep the same approach in focus to help you get the best value for your $$s.
    Ever Growing Inventory
    Ranging from the smallest feasible / required data (datasheets, data facts, SWOT analysis, company profiles, etc) to full research reports that help you make decisions, our inventory is updated almost on a daily basis with the latest industry reports from domain experts that track more than 5000 niche sectors.
    One Stop Solution
    Need a custom research report on medical devices market? Require all available business intelligence on 3D printing industry? Exploring F&B sector of a particular country/region? RnRMarketResearch.com is your one-stop-solution to all market intelligence needs. We not only offer custom research and consulting services, we also "bundle" reports to meet your needs and help you fetch the data analysis you require for your business.
    Dedicated Client Engagement
    Not limited to only "finding" relevant reports for you, our client engagement team dedicates its efforts to understand your "business need" and accordingly maps available research data to help you move forward. Call "your" client engagement executive any time of your day and get your questions answered in order to make the correct business decision.
    Saving Time and Efforts
    Simply share your research requirement details with us and let us do all the hard work to find required intelligence for you. When you add up our "one stop solution" and "dedicated client engagement" services mentioned above, you obviously know the time and effort saving you do by working with us.
    Payment Flexibility
    Working with Fortune 500 organizations, we understand the importance of being flexible for payments. Share your payment terms with us and we will surely match up to them to ensure you get access to required business intelligence data without having to wait for the payment to be done.
    Post-Purchase Research Support
    Have questions after reading a report / datasheet bought through us? Not sure about the methodology used for data available in the research? Talk to us / Share your questions with us and if required, we will connect you with the analyst(s)/author(s) of the report(s) and ensure you get satisfactory answers for the same. Need more data / analysis / report(s) on the topic of your research/project? The RnRMarketResearch.com team is here for you 24X7 to support you with your post-purchase requirements. Subscription Offers & Packages (Get in touch with us for more details - [email protected] / +1 888 391 5441 )
    • Ad Hoc
    • Pay - as - you - go / Bucket Subscriptions
    • Fixed Cost for #of reports
    • Customize / Personalize as per your needs